title: [Gene expression analyses and their possible clinical benefit in  head and neck cancer].
abstract: Systems biology approaches for mutational (exome analysis and targeted sequencing) and gene expression analysis (transcriptome-wide gene expression profiling) represent a new and growing scientific field in head and neck oncology. In addition to medical biological expertise, bioinformatic assistance is increasingly required. For squamous cell head and neck cancer (HNSCC), the recent molecular genetic single-gene and signal pathway observations represent basic research. Important aspects of this have now been significantly enhanced by systems biology approaches, which have grown into relevant areas of translational clinical research. It is now known that HPV16 is associated with genetic alterations at various locations, but also that it functionally affects genes not altered in their base sequence at the level of methylation. In transcriptome analyses, various consortia found matching clusters of gene expression and HPV16 association with the spectrum of somatic mutations. The differential methylation of gene promoters discovered in HPV16-driven HNSCC proved predictive for survival—even in HNSCC patients without HPV detection. The authors present an overview of some translationally relevant findings and venture an outlook on possible future clinical developments.
authors.affiliation: Hals-Nasen-Ohren-Universitätsklinik Leipzig, Leipzig, Deutschland
authors.forename: A
authors.initials: A
authors.lastname: Dietz
authors.forename: M
authors.initials: M
authors.lastname: Loeffler
authors.forename: M
authors.initials: M
authors.lastname: Rosolowski
authors.forename: M
authors.initials: M
authors.lastname: Kreuz
authors.forename: F
authors.initials: F
authors.lastname: Lordick
authors.forename: M
authors.initials: M
authors.lastname: Knödler
authors.forename: C
authors.initials: C
authors.lastname: Mozet
authors.forename: G
authors.initials: G
authors.lastname: Wichmann
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics*; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis* / Q000453:epidemiology / Q000235:genetics*; D015984:Causality; D015897:Comorbidity; D004252:DNA Mutational Analysis / Q000379:methods; D020869:Gene Expression Profiling / Q000379:methods*; D005820:Genetic Testing / Q000379:methods*; D006258:Head and Neck Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000235:genetics*; D006801:Humans; D030361:Papillomavirus Infections / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D015995:Prevalence; D018570:Risk Assessment / Q000379:methods; D000077195:Squamous Cell Carcinoma of Head and Neck
chemical_list: D014408:Biomarkers, Tumor